It is a pharma private limited company based in Delhi, Delhi, India, established in 2005.
2005 | Delhi, Delhi, India | ActiveAman Drugs Private Limited, a active private limited company, was established on 16 February 2005 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233DL2005PTC133070. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.65 M.
It upholds a compliant status. Employing 4 professional, Its leadership includes Krishna Sachan (Director), Pradip Sachan (Director), Savitri Devi (Director). Past directors included Aman Sachan, Shaligram Sachan, Arun Kumar Sachan. It holds no open charges and ₹9.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.190, B-3 (Basement), Functional Industrial Estate, Patparganj, Delhi, Delhi, 110092.
U24233DL2005PTC133070
133070
16 February 2005
₹1.50 M
₹0.65 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Aman Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Sachan | Director | 16 Feb 2005 | Current |
| Pradip Sachan | Director | 16 Feb 2005 | Current |
| Savitri Devi | Director | 16 Feb 2005 | Current |
| Shalini Sachan | Director | 16 Feb 2005 | Current |
| Arun Kumar Sachan | Director | 08 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 Aug 2017 | Past |
| Pramod Abcsdd | Director | 07 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aman Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.87% increase. The company also saw a substantial improvement in profitability, with a 209.73% increase in profit. The company's net worth moved up by a moderate rise of 0.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aman Drugs had a public holding of 21.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹98,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2016 | Others | ₹0.30 M | Satisfied |
| 21 May 2012 | Standard Chartered Bank | ₹3.30 Cr | Satisfied |
| 21 May 2012 | Standard Chartered Bank | ₹6.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Aman Drugs has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aman Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aman Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aman Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aman Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge registered on 25 Aug 2016 via Charge ID 100054574 with Others was fully satisfied on 20 Oct 2020. was documented.
The activity A charge registered on 21 May 2012 via Charge ID 10365584 with Standard Chartered Bank was fully satisfied on 20 Oct 2020. was completed.
A charge registered on 21 May 2012 via Charge ID 10365596 with Standard Chartered Bank was fully satisfied on 20 Oct 2020. was recorded as a recent event.
A charge with Others amounted to Rs. 0.30 M with Charge ID 100054574 was registered on 25 Aug 2016. was recorded as a recent event.
The CIN of Aman Drugs Private Limited is U24233DL2005PTC133070.
Aman Drugs Private Limited is headquartered at Plot No.190, B-3 (Basement), Functional Industrial Estate, Patparganj, Delhi, Delhi, 110092.
Aman Drugs Private Limited was incorporated on 16 February 2005.
The current directors of Aman Drugs Private Limited are
The primary industry of Aman Drugs Private Limited is Trade.
Aman Drugs Private Limited is unlisted.
The authorized capital of Aman Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹0.65 M.
The compliance status of Aman Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX